NCT03317899 · BASELINE

Baseline characteristics

Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma · Source last updated 2025-12-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
38
group Id
BG001
value
39
group Id
BG002
value
77
units
Participants

groups

description
Beginning on day 3 after auto Hematopoietic Cell Transplantation (HSCT), patients receive tbo-filgrastim SC daily for 12-14 days. Hematopoietic Cell Transplantation: Undergo auto HSCT Tbo-filgrastim: Given subcutaneously Laboratory Biomarker Analysis: Correlative Studies
id
BG000
title
Group I (Auto HSCT Tbo-filgrastim)
description
Patients undergo auto Hematopoietic Cell Transplantation (HSCT). Hematopoietic Cell Transplantation: Undergo auto HSCT Laboratory Biomarker Analysis: Correlative Studies
id
BG001
title
Group II (Auto HSCT)
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
29
group Id
BG001
value
20
group Id
BG002
value
49
title
Between 18 and 65 years
measurements
group Id
BG000
value
9
group Id
BG001
value
19
group Id
BG002
value
28
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
20
group Id
BG002
value
32
title
Female
measurements
group Id
BG000
value
26
group Id
BG001
value
19
group Id
BG002
value
45
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
2
group Id
BG002
value
6
title
Hispanic or Latino
measurements
group Id
BG000
value
33
group Id
BG001
value
37
group Id
BG002
value
70
title
Not Hispanic or Latino
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
American Indian or Alaska Native
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
9
group Id
BG001
value
9
group Id
BG002
value
18
title
Black or African American
measurements
group Id
BG000
value
24
group Id
BG001
value
27
group Id
BG002
value
51
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
5
group Id
BG001
value
3
group Id
BG002
value
8
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

Complete source fields

denoms

counts
group Id
BG000
value
38
group Id
BG001
value
39
group Id
BG002
value
77
units
Participants

groups

description
Beginning on day 3 after auto Hematopoietic Cell Transplantation (HSCT), patients receive tbo-filgrastim SC daily for 12-14 days. Hematopoietic Cell Transplantation: Undergo auto HSCT Tbo-filgrastim: Given subcutaneously Laboratory Biomarker Analysis: Correlative Studies
id
BG000
title
Group I (Auto HSCT Tbo-filgrastim)
description
Patients undergo auto Hematopoietic Cell Transplantation (HSCT). Hematopoietic Cell Transplantation: Undergo auto HSCT Laboratory Biomarker Analysis: Correlative Studies
id
BG001
title
Group II (Auto HSCT)
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
<=18 years
measurements
group Id
BG000
value
29
group Id
BG001
value
20
group Id
BG002
value
49
title
Between 18 and 65 years
measurements
group Id
BG000
value
9
group Id
BG001
value
19
group Id
BG002
value
28
title
>=65 years
param Type
COUNT_OF_PARTICIPANTS
title
Age, Categorical
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
20
group Id
BG002
value
32
title
Female
measurements
group Id
BG000
value
26
group Id
BG001
value
19
group Id
BG002
value
45
title
Male
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
4
group Id
BG001
value
2
group Id
BG002
value
6
title
Hispanic or Latino
measurements
group Id
BG000
value
33
group Id
BG001
value
37
group Id
BG002
value
70
title
Not Hispanic or Latino
measurements
group Id
BG000
value
1
group Id
BG001
value
0
group Id
BG002
value
1
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Ethnicity (NIH/OMB)
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
American Indian or Alaska Native
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Asian
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
Native Hawaiian or Other Pacific Islander
measurements
group Id
BG000
value
9
group Id
BG001
value
9
group Id
BG002
value
18
title
Black or African American
measurements
group Id
BG000
value
24
group Id
BG001
value
27
group Id
BG002
value
51
title
White
measurements
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
title
More than one race
measurements
group Id
BG000
value
5
group Id
BG001
value
3
group Id
BG002
value
8
title
Unknown or Not Reported
param Type
COUNT_OF_PARTICIPANTS
title
Race (NIH/OMB)
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice